10 drugs now in shortage beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.
"We know from all medical interventions, stay time is not like a 100%. but I think we will see a significantly higher stay time than what we have seen so far on obesity treatment," said Lars Fruergaard Jorgensen at the JPMorgan Healthcare conference in San Francisco. The Danish drugmaker's chief executive said the effects patients see after being on Wegovy would be an incentive for them to continue, although it may be "too early to tell." Novo and U.S. drugmaker Eli Lilly currently dominate the market for new weight loss drugs that analysts have forecast could be worth $100 billion by the end of the decade.
Semaglutide, the active ingredient in the injectable diabetes drug Ozempic and its weight-loss sister prescription Wegovy, seems to have yet another unfortunate side effect: putting back on the weight, and then some, when one stops taking it. As two women told The Messenger in interviews about their experiences with the injectable drugs, the weight gain wasn't […]